Extended-spectrum β-lactamase-producing Enterobacteriaceae as a common cause of urinary tract infections in Sri Lanka

Infection and Chemotherapy

Volumn 48, Issue 3, 2016, Pages 160-165

  Tillekeratne, L Gayani ^a   Vidanagama, Dhammika ^b   Tippalagama, Rashmi ^c   Lewkebandara, Rashmi ^b   Joyce, Maria ^d   Nicholson, Bradly P ^d   Nagahawatte, Ajith ^e   Bodinayake, Champica K ^e   De Silva, Aruna Dharshan ^c   Woods, Christopher W ^a  

^a DUKE UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b Teaching Hospital Karapitiya   (Sri Lanka)

^c Genetech Research Institute   (Sri Lanka)

^d DURHAM VA MEDICAL CENTER   (United States)

^e UNIVERSITY OF RUHUNA   (Sri Lanka)

Author keywords

Community acquired urinary tract infections; Enterobacteriaceae; Extended spectrum lactamases; Sri Lanka

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; BETA LACTAMASE CTX M; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFAZOLIN; CEFOTAXIME; CEFTAZIDIME; CEFTRIAXONE; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; COTRIMOXAZOLE; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; PIPERACILLIN PLUS TAZOBACTAM; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TOBRAMYCIN;

ADOLESCENT; ANTIBIOTIC SENSITIVITY; ANTIBIOTIC THERAPY; ARTICLE; BACTERIAL GENE; BACTERIUM DETECTION; BACTERIUM ISOLATE; CHILD; CLINICAL ARTICLE; DEMOGRAPHY; DIABETIC PATIENT; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE INFECTION; EPIDEMIOLOGICAL DATA; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ENTEROBACTERIACEAE; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING ESCHERICHIA COLI; EXTENDED SPECTRUM BETA LACTAMASE PRODUCING KLEBSIELLA PNEUMONIAE; FEMALE; HUMAN; LABORATORY TEST; MALE; MEDICAL RECORD; NONHUMAN; POLYMERASE CHAIN REACTION; PREVALENCE; PROSPECTIVE STUDY; PYELONEPHRITIS; SPECIES IDENTIFICATION; SRI LANKA; TERTIARY CARE CENTER; URINARY TRACT INFECTION; URINE SAMPLING;

EID: 84992184291     PISSN: 20932340     EISSN: 20926448     Source Type: Journal    
DOI: 10.3947/ic.2016.48.3.160     Document Type: Article

References (30)

1. Livermore DM. Fourteen years in resistance. Int J Antimicrob Agents 2012;39:283-94.
2. Wellington EM, Boxall AB, Cross P, Feil EJ, Gaze WH, Hawkey PM, Johnson-Rollings AS, Jones DL, Lee NM, Otten W,Thomas CM, Williams AP. The role of the natural environment in the emergence of antibiotic resistance in gram-negative bacteria. Lancet Infect Dis 2013;13:155-65.
3. Hammami S, Saidani M, Ferjeni S, Aissa I, Slim A, Boutiba-Ben Boubaker I. Characterization of extended spectrum β-lactamase-producing Escherichia coli in community-acquired urinary tract infections in Tunisia. Microb Drug Resist 2013;19:231-6.
4. Lau SM, Peng MY, Chang FY. Resistance rates to commonly used antimicrobials among pathogens of both bacteremic and non-bacteremic community-acquired urinary tract infection. J Microbiol Immunol Infect 2004;37:185-91.
5. Meier S, Weber R, Zbinden R, Ruef C, Hasse B. Extended-spectrum β-lactamase-producing Gram-negative pathogens in community-acquired urinary tract infections: an increasing challenge for antimicrobial therapy. Infection 2011;39:333-40.
6. ARSP Working Group. The Sri Lanka College of Microbiology. A multi centre laboratory study of Gram negative bacterial blood stream infections in Sri Lanka. Ceylon Med J 2013;58:56-61.
7. Dissayanake D, Fernando S, Chandrasiri N. The distribution and characteristics of Extended-Spectrum β-Lactamase producing Escherichia coli and Klebsiella species among urinary isolates in a tertiary care hospital. Sri Lankan J Infect Dis 2012;2:30-6.
8. Patabendige C, Chandrasiri N, Karunanayake L, Karunaratne G, Somaratne P, Elwitigala J, Chandrasiri P. Antimicrobial resistance in resource-poor settings-Sri Lankan experience. Regional Health Forum 2011;15:18-26.
9. Centers for Disease Control and Prevention (CDC). Device-associated module (UTI). Available at: http://www.cdc.gov/nhsn/PDFs/pscManual/7pscCAUTIcurrent.pdf. Accessed 3 April 2016.
10. Horcajada JP, Shaw E, Padilla B, Pintado V, Calbo E, Benito N, Gamallo R, Gozalo M, Rodríguez-Baño J; ITUBRAS group; Grupo de Estudio de Infección Hospitalaria (GEIH); Sociedad Española de Enfermedades Infecciosas y Microbiología Clínica (SEIMC). Healthcare-associated, community-acquired and hospital-acquired bacteraemic urinary tract infections in hospitalized patients: a prospective multicentre cohort study in the era of antimicrobial resistance. Clin Microbiol Infect 2013;19:962-8.
11. th ed. Wayne, PA: CLSI; 2012.
12. Centers for Disease Control and Prevention (CDC). Laboratory detection of extended-spectrum beta-lactamases (ESBLs). Available at: http://www.cdc.gov/HAI/settings/lab/lab_esbl.html. Accessed 5 May 2015.
13. Centers for Disease Control and Prevention (CDC). Modified hodge test for carbapenemase detection in Enterobacteriaceae. Available at: http://www.cdc.gov/HAI/pdfs/labSettings/HodgeTest_Carbapenemase_Enterobacteriaceae.pdf. Accessed 5 May 2015.
14. Barguigua A, El Otmani F, Talmi M, Bourjilat F, Haouzane F, Zerouali K, Timinouni M. Characterization of extended-spectrum β-lactamase-producing Escherichia coli and Klebsiella pneumoniae isolates from the community in Morocco. J Med Microbiol 2011;60:1344-52.
15. American Thoracic Society; Infectious Diseases Society of America. Guidelines for the management of adults with hospital-acquired, ventilator-associated, and healthcare-associated pneumonia. Am J Respir Crit Care Med 2005;171:388-416.
16. Woerther PL, Burdet C, Chachaty E, Andremont A. Trends in human fecal carriage of extended-spectrum beta-lactamases in the community: toward the globalization of CTX-M. Clin Microbiol Rev 2013;26:744-58.
17. Chander A, Shrestha CD. Prevalence of extended spectrum beta lactamase producing Escherichia coli and Klebsiella pneumoniae urinary isolates in a tertiary care hospital in Kathmandu, Nepal. BMC Res Notes 2013;6:487.
18. Nandagopal B, Sankar S, Sagadevan K, Arumugam H, Jesudason MV, Aswathaman K, Nair A. Frequency of extended spectrum β-lactamase producing urinary isolates of Gram-negative bacilli among patients seen in a multispecialty hospital in Vellore district, India. Indian J Med Microbiol 2015;33:282-5.
19. Bajpai T, Pandey M, Varma M, Bhatambare GS. Prevalence of extended spectrum beta-lactamase producing uropathogens and their antibiotic resistance profile in patients visiting a tertiary care hospital in central India: Implications on empiric therapy. Indian J Pathol Microbiol 2014;57:407-12.
20. Mukherjee M, Basu S, Mukherjee SK, Majumder M. Multidrug-resistance and extended spectrum beta-lactamase production in uropathogenic E. coli which were isolated from hospitalized patients in Kolkata, India. J Clin Diagn Res 2013;7:449-53.
21. Habeeb MA, Sarwar Y, Ali A, Salman M, Haque A. Rapid emergence of ESBL producers in E. coli causing urinary and wound infections in Pakistan. Pak J Med Sci 2013;29:540-4.
22. Calbo E, Romani V, Xercavins M, Gomez L, Vidal CG, Quintana S, Vila J, Garau J. Risk factors for community-onset urinary tract infections due to Escherichia coli harbouring extended-spectrum beta-lactamases. J Antimicrob Chemother 2006;57:780-3.
23. Dortet L, Brechard L, Grenet K, Nguessan MS, Nordmann P. Sri Lanka, another country from the Indian subcontinent with NDM-1-producing Enterobacteriaceae. J Antimicrob Chemother 2013;68:2172-3.
24. Papagiannitsis CC, Studentova V, Chudackova E, Bergerova T, Hrabak J, Radej J, Novak I. Identification of a New Delhi metallo-β-lactamase-4 (NDM-4)-producing Enterobacter cloacae from a Czech patient previously hospitalized in Sri Lanka. Folia Microbiol (Praha) 2013;58:547-9.
25. Hall JM, Corea E, Sanjeewani HD, Inglis TJ. Molecular mechanisms of β-lactam resistance in carbapenemase-producing Klebsiella pneumoniae from Sri Lanka. J Med Microbiol 2014;63:1087-92.
26. Woodford N, Ward ME, Kaufmann ME, Turton J, Fagan EJ, James D, Johnson AP, Pike R, Warner M, Cheasty T, Pearson A, Harry S, Leach JB, Loughrey A, Lowes JA, Warren RE, Livermore DM. Community and hospital spread of Escherichia coli producing CTX-M extended-spectrum beta-lactamases in the UK. J Antimicrob Chemother 2004;54:735-43.
27. Smet A, Martel A, Persoons D, Dewulf J, Heyndrickx M, Claeys G, Lontie M, Van Meensel B, Herman L, Haesebrouck F, Butaye P. Characterization of extended-spectrum beta-lactamases produced by Escherichia coli isolated from hospitalized and nonhospitalized patients: emergence of CTX-M-15-producing strains causing urinary tract infections. Microb Drug Resist 2010;16:129-34.
28. Chen LF, Freeman JT, Nicholson B, Keiger A, Lancaster S, Joyce M, Woods CW, Cook E, Adcock L, Louis S, Cromer AL, Sexton DJ, Anderson DJ. Widespread dissemination of CTX-M-15 genotype extended-spectrum-β-lactamase-producing enterobacteriaceae among patients presenting to community hospitals in the southeastern United States. Antimicrob Agents Chemother 2014;58:1200-2.
29. Harris AD, Kotetishvili M, Shurland S, Johnson JA, Morris JG, Nemoy LL, Johnson JK. How important is patient-to-patient transmission in extended-spectrum beta-lactamase Escherichia coli acquisition. Am J Infect Control 2007;35:97-101.
30. Woerther PL, Angebault C, Jacquier H, Hugede HC, Janssens AC, Sayadi S, El Mniai A, Armand-Lefèvre L, Ruppé E,Barbier F, Raskine L, Page AL, de Rekeneire N, Andremont A. Massive increase, spread, and exchange of extended spectrum β-lactamase-encoding genes among intestinal Enterobacteriaceae in hospitalized children with severe acute malnutrition in Niger. Clin Infect Dis 2011;53:677-85.